Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer - Ingold Heppner, B; Untch, M; Denkert, C (Clin Cancer Res, 2016)
et al.